Abstract

Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2016 - Volume 20, Number 5

Page(s): 407

Download in electronic PDF format for $75

Abstract

A formulation for preparing Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2016 Pg. 407	Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 336-343	Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Author(s): Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2002 Pg. 298	Estriol 2-mg/mL, Estrone 0.25-mg/mL, and Estradiol 0.25-mg/mL Topical Solution Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 238	Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2002 Pg. 255-256	Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women Author(s): Mason Dave
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 52-54	Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Author(s): Ford Gina, Garcia Lea
Sep/Oct 2001 Pg. 375	Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 250-256	A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Author(s): Gillson George R, Zava David T
Nov/Dec 2018 Pg. 504-511	Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) Author(s): Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
Jan/Feb 2024 Pg. 75-81	Compatibility of Various Hormones in Phytobase and HRT Heavy Cream Bases Author(s): Taylor Sarah, Haselhorst Rodney
Jul/Aug 2024 Pg. 344-350	Extended Chemical and Microbial Stability of Various Hormones in Phytobase and HRT Heavy Cream Bases Author(s): Taylor Sarah, Haselhorst Rodney
Mar/Apr 2021 Pg. 156-162	Stability of Fagron's Phytobase Cream Compounded with Various Hormones Author(s): Wynn Tom, Taylor Sarah, Zander Clark
Mar/Apr 2020 Pg. 98-102	Compounding Pearls -- Wound Care: Base Selection Author(s): Riepl Mike
Jul/Aug 2002 Pg. 303-304	Topical Oil-in-Water Cream Bases, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 392-399	Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing Author(s): Kells John, Dollbaum Charles M
Nov/Dec 2000 Pg. 458	Estriol and Estradiol 2.5-mg, Progesterone 50-mg, and Testosterone 1-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 447-454	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Author(s): Deleruyelle Laura J
Jan/Feb 2015 Pg. 6-12	Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi